| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 2.48e-10 | 441 | 190 | 22 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ZRANB3 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ATP6V0A4 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 4.77e-09 | 614 | 190 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 3.26e-08 | 11 | 190 | 5 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | ABCA10 ABCB1 ABCB4 ATP2C2 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.94e-07 | 109 | 190 | 9 | GO:0042626 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.05e-06 | 36 | 190 | 6 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.05e-06 | 36 | 190 | 6 | GO:0015662 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.25e-06 | 37 | 190 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ARL4C ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 1.39e-06 | 775 | 190 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.47e-06 | 38 | 190 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | IRAK2 ERVK-7 ERVK-10 MELK PARP4 KARS1 NEK5 STK39 PARP9 OXSR1 DMPK TAF1L NTRK3 ROR1 NOL9 CIT POLR3A GRK1 LATS1 TIE1 HASPIN ERVK-8 ROCK1 PALS2 RIOK2 | 3.22e-06 | 938 | 190 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ARL4C ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 5.21e-06 | 839 | 190 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ARL4C ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 5.31e-06 | 840 | 190 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSP90B1 KIF1A SRP54 MCM2 ABCA10 ABCB1 ABCB4 ATP2C2 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DHX57 RECQL DDX55 ARL4C ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 5.31e-06 | 840 | 190 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | transcription corepressor activity | ZMYND8 SSX9P TSG101 SSX6P SSX7 SSX1 SSX5 PARP9 CBX4 SNW1 SSX3 | 1.28e-05 | 229 | 190 | 11 | GO:0003714 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.46e-05 | 151 | 190 | 9 | GO:0015085 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.35e-05 | 123 | 190 | 8 | GO:0030165 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.71e-05 | 62 | 190 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 4.73e-05 | 42 | 190 | 5 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 4.73e-05 | 42 | 190 | 5 | GO:0004812 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | ABCA10 ABCB1 ABCB4 ATP2C2 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.35e-05 | 178 | 190 | 9 | GO:0015399 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.32e-04 | 11 | 190 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | EARS2 ERVK-7 ERVK-10 KARS1 SARS1 PAN2 WARS1 DHX57 DDX55 POLR3A HARS2 ERVK-8 CMTR2 | 1.88e-04 | 417 | 190 | 13 | GO:0140098 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A17 ABCA10 ABCB1 ABCB4 SLC38A1 ATP2C2 SLC12A6 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SLC25A31 | 1.99e-04 | 477 | 190 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | protein kinase activity | IRAK2 MELK NEK5 STK39 OXSR1 DMPK TAF1L NTRK3 ROR1 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 RIOK2 | 2.09e-04 | 600 | 190 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | ceramide floppase activity | 2.69e-04 | 3 | 190 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.86e-04 | 14 | 190 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | kinase activity | IRAK2 MELK NEK5 STK39 OXSR1 DMPK TAF1L NTRK3 ROR1 NOL9 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 PALS2 RIOK2 | 3.80e-04 | 764 | 190 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | IRAK2 MELK NEK5 STK39 OXSR1 DMPK TAF1L NTRK3 ROR1 NOL9 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 RIOK2 | 4.54e-04 | 709 | 190 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EARS2 MCM2 ERVK-7 ERVK-10 ZRANB3 KARS1 SARS1 PAN2 WARS1 DHX57 RECQL DDX55 POLR3A HARS2 ERVK-8 CMTR2 | 4.64e-04 | 645 | 190 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 5.23e-04 | 17 | 190 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A RYR2 RYR3 SLC38A1 ATP2C2 SLC12A6 TPCN2 TRPC7 SLC5A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.32e-04 | 465 | 190 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.34e-04 | 4 | 190 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 5.34e-04 | 4 | 190 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.43e-04 | 70 | 190 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 6.23e-04 | 18 | 190 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.41e-04 | 152 | 190 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.94e-04 | 21 | 190 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A RYR2 RYR3 SLC38A1 ATP2C2 SLC12A6 TPCN2 TRPC7 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 1.01e-03 | 627 | 190 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MELK NEK5 STK39 OXSR1 DMPK TAF1L CIT GRK1 LATS1 HASPIN ROCK1 RIOK2 | 1.21e-03 | 446 | 190 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.32e-03 | 6 | 190 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligase activity | 1.41e-03 | 174 | 190 | 7 | GO:0016874 | |
| GeneOntologyMolecularFunction | tRNA binding | 1.46e-03 | 87 | 190 | 5 | GO:0000049 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.66e-03 | 230 | 190 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 1.67e-03 | 25 | 190 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | ARPP19 ANKRD36C MYOZ1 SERPINB12 PARP9 C5 TAF1L VTI1B WARS1 CIT ROCK1 ATP2B1 ATP2B4 ENSA | 1.75e-03 | 596 | 190 | 14 | GO:0140678 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A RYR2 RYR3 SLC38A1 ATP2C2 SLC12A6 TPCN2 TRPC7 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 1.77e-03 | 664 | 190 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.96e-03 | 93 | 190 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.26e-03 | 58 | 190 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 2.43e-03 | 8 | 190 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC38A1 ATP2C2 SLC12A6 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.43e-03 | 301 | 190 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.58e-03 | 363 | 190 | 10 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.69e-03 | 100 | 190 | 5 | GO:0019888 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.13e-03 | 31 | 190 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | chemokine binding | 3.75e-03 | 33 | 190 | 3 | GO:0019956 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.75e-03 | 33 | 190 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A SLC6A17 ABCA10 RYR2 RYR3 ABCB1 ABCB4 SLC38A1 ATP2C2 SLC12A6 TPCN2 TRPC7 GSDMC SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SLC25A31 ATP5F1C | 4.28e-03 | 1180 | 190 | 21 | GO:0022857 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 DMPK TPCN2 TRPC7 CAPN3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.44e-06 | 359 | 184 | 14 | GO:0006874 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.34e-06 | 29 | 184 | 5 | GO:1903779 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.02e-05 | 84 | 184 | 7 | GO:0051480 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 DMPK TPCN2 TRPC7 CAPN3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.11e-05 | 389 | 184 | 14 | GO:0055074 |
| GeneOntologyBiologicalProcess | chemokine (C-X-C motif) ligand 12 signaling pathway | 2.38e-05 | 7 | 184 | 3 | GO:0038146 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A SLC6A17 RYR2 RYR3 SLC38A1 CXCR4 ATP2C2 STK39 KIF5B OXSR1 DMPK HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 OPRD1 SLC5A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 3.03e-05 | 1000 | 184 | 23 | GO:0030001 |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.19e-05 | 100 | 184 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | tRNA aminoacylation for protein translation | 3.48e-05 | 42 | 184 | 5 | GO:0006418 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A SLC6A17 RYR2 RYR3 SLC38A1 CXCR4 ATP2C2 STK39 KIF5B OXSR1 DMPK HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 OPRD1 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 3.74e-05 | 1157 | 184 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | tRNA aminoacylation | 4.89e-05 | 45 | 184 | 5 | GO:0043039 | |
| GeneOntologyBiologicalProcess | amino acid activation | 5.45e-05 | 46 | 184 | 5 | GO:0043038 | |
| GeneOntologyBiologicalProcess | heart contraction | SCN11A RYR2 CXCR4 DMPK DSP CTNNA3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 7.89e-05 | 298 | 184 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A SLC6A17 RYR2 RYR3 SLC38A1 ATP2C2 STK39 OXSR1 HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 7.89e-05 | 922 | 184 | 21 | GO:0098662 |
| GeneOntologyBiologicalProcess | circulatory system process | SCN11A SLC6A17 ITGA4 RYR2 ABCB1 SLC38A1 CXCR4 STK39 FGG DMPK DSP CTNNA3 ROCK1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 1.04e-04 | 733 | 184 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A SLC6A17 RYR2 RYR3 SLC38A1 ATP2C2 STK39 OXSR1 HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 1.07e-04 | 942 | 184 | 21 | GO:0098655 |
| GeneOntologyBiologicalProcess | heart process | SCN11A RYR2 CXCR4 DMPK DSP CTNNA3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 1.09e-04 | 309 | 184 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | intracellular protein transport | HSP90B1 KIF1A SRP54 TSG101 UBE2G2 XPO5 EXOC6B LRRC7 KIF5B KIF5C MMP12 HSPA9 SEC23B VTI1B SEL1L EXOC6 VTI1A ARL4C | 1.17e-04 | 740 | 184 | 18 | GO:0006886 |
| GeneOntologyBiologicalProcess | cellular hypotonic response | 1.45e-04 | 12 | 184 | 3 | GO:0071476 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.45e-04 | 12 | 184 | 3 | GO:0098911 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 STK39 DMPK SLC12A6 TPCN2 TRPC7 CAPN3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.51e-04 | 622 | 184 | 16 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 STK39 DMPK TPCN2 TRPC7 CAPN3 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.51e-04 | 622 | 184 | 16 | GO:0006873 |
| GeneOntologyBiologicalProcess | regulation of blood circulation | ITGA4 RYR2 FGG DMPK DSP CTNNA3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 1.74e-04 | 326 | 184 | 11 | GO:1903522 |
| GeneOntologyBiologicalProcess | DNA integration | 1.87e-04 | 13 | 184 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A SLC6A17 SLC38A1 STK39 OXSR1 DMPK TPCN2 SLC5A4 ATP2B4 SNTA1 | 1.89e-04 | 275 | 184 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | calcium ion transport | SCN11A RYR2 RYR3 CXCR4 ATP2C2 HSPA9 TPCN2 TRPC7 CAPN3 OPRD1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.99e-04 | 509 | 184 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.02e-04 | 178 | 184 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | SCN11A RYR2 RYR3 ATP2C2 HSPA9 TPCN2 TRPC7 CAPN3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.18e-04 | 392 | 184 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A SLC6A17 RYR2 RYR3 ABCB1 SLC38A1 CXCR4 ATP2C2 STK39 KIF5B OXSR1 DMPK HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 OPRD1 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 2.25e-04 | 1374 | 184 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.29e-04 | 62 | 184 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 2.36e-04 | 3 | 184 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | hypotonic response | 2.36e-04 | 14 | 184 | 3 | GO:0006971 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 STK39 DMPK SLC12A6 TPCN2 TRPC7 CAPN3 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.45e-04 | 717 | 184 | 17 | GO:0050801 |
| GeneOntologyBiologicalProcess | muscle contraction | SCN11A RYR2 RYR3 CXCR4 DMPK TPCN2 DSP CTNNA3 ROCK1 ATP2B1 ATP2B4 SNTA1 | 2.62e-04 | 400 | 184 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 STK39 KIF5B DMPK SLC12A6 TPCN2 TRPC7 CAPN3 RFX6 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.82e-04 | 866 | 184 | 19 | GO:0055082 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A SLC6A17 RYR2 RYR3 SLC38A1 ATP2C2 STK39 OXSR1 HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 3.03e-04 | 1017 | 184 | 21 | GO:0098660 |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 3.22e-04 | 37 | 184 | 4 | GO:0086005 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 DMPK TPCN2 TRPC7 CAPN3 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.98e-04 | 611 | 184 | 15 | GO:0030003 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A SLC6A17 RYR2 RYR3 ABCB1 SLC38A1 ATP2C2 STK39 OXSR1 HSPA9 SLC12A6 TPCN2 TRPC7 CAPN3 SLC5A4 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 4.04e-04 | 1115 | 184 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 4.12e-04 | 249 | 184 | 9 | GO:0008016 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 4.33e-04 | 17 | 184 | 3 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 4.33e-04 | 17 | 184 | 3 | GO:0098840 | |
| GeneOntologyBiologicalProcess | calcium ion export | 4.69e-04 | 4 | 184 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 STK39 KIF5B OXSR1 DMPK SLC12A6 TPCN2 TRPC7 CAPN3 RFX6 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.98e-04 | 981 | 184 | 20 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | RYR2 CXCR4 ATP2C2 STK39 KIF5B OXSR1 DMPK CAPN3 OPRD1 ATP2B1 ATP2B2 ATP2B4 SNTA1 | 5.02e-04 | 493 | 184 | 13 | GO:0010959 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 5.74e-04 | 208 | 184 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | HSP90B1 ERC1 RYR2 RYR3 ATP2C2 PKHD1 DMPK SLC12A6 TPCN2 TRPC7 CAPN3 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 6.02e-04 | 705 | 184 | 16 | GO:0055080 |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 6.63e-04 | 266 | 184 | 9 | GO:0043270 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | RYR2 ABCB1 CXCR4 ATP2C2 STK39 KIF5B OXSR1 DMPK CAPN3 OPRD1 ATP2B1 ATP2B2 ATP2B4 SNTA1 | 6.97e-04 | 577 | 184 | 14 | GO:0043269 |
| GeneOntologyBiologicalProcess | blood circulation | SCN11A ITGA4 RYR2 CXCR4 STK39 FGG DMPK DSP CTNNA3 ROCK1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 7.30e-04 | 648 | 184 | 15 | GO:0008015 |
| GeneOntologyCellularComponent | cilium | CCP110 ERC1 SSX9P SSX6P SSX7 SSX1 SSX5 PKHD1 KIF5B KIF5C DNAH6 DNAAF4 IFT81 ARFGEF2 AKAP3 GRK1 IFT88 TTC21B SSX3 ATP2B2 ATP2B4 SLC25A31 CCDC63 | 6.89e-06 | 898 | 189 | 23 | GO:0005929 |
| GeneOntologyCellularComponent | 9+2 motile cilium | SSX9P SSX6P SSX7 SSX1 SSX5 DNAH6 IFT81 AKAP3 IFT88 SSX3 ATP2B4 | 1.14e-05 | 238 | 189 | 11 | GO:0097729 |
| GeneOntologyCellularComponent | sperm flagellum | 2.62e-05 | 214 | 189 | 10 | GO:0036126 | |
| GeneOntologyCellularComponent | motile cilium | SSX9P SSX6P SSX7 SSX1 SSX5 DNAH6 IFT81 AKAP3 IFT88 SSX3 ATP2B4 SLC25A31 | 9.87e-05 | 355 | 189 | 12 | GO:0031514 |
| MousePheno | abnormal mitosis | 6.47e-06 | 128 | 143 | 9 | MP:0004046 | |
| Domain | KRAB_RELATED | 2.19e-12 | 11 | 180 | 7 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 1.12e-11 | 13 | 180 | 7 | IPR003655 | |
| Domain | SSX | 4.68e-10 | 6 | 180 | 5 | IPR028804 | |
| Domain | SSXRD | 4.30e-09 | 8 | 180 | 5 | PF09514 | |
| Domain | SSXRD_motif | 4.30e-09 | 8 | 180 | 5 | IPR019041 | |
| Domain | ATP_Ca_trans_C | 8.35e-09 | 4 | 180 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 8.35e-09 | 4 | 180 | 4 | PF12424 | |
| Domain | P-type_ATPase_IIB | 8.35e-09 | 4 | 180 | 4 | IPR006408 | |
| Domain | ATPase_P-typ_TM_dom | 3.15e-07 | 16 | 180 | 5 | IPR023298 | |
| Domain | - | 3.15e-07 | 16 | 180 | 5 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.43e-07 | 17 | 180 | 5 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.43e-07 | 17 | 180 | 5 | PF00689 | |
| Domain | Cation_ATPase_N | 6.09e-07 | 18 | 180 | 5 | PF00690 | |
| Domain | Cation_ATPase_N | 6.09e-07 | 18 | 180 | 5 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 8.20e-07 | 19 | 180 | 5 | IPR004014 | |
| Domain | DCB_dom | 3.50e-06 | 4 | 180 | 3 | IPR032629 | |
| Domain | Sec7_C | 3.50e-06 | 4 | 180 | 3 | IPR015403 | |
| Domain | DUF1981 | 3.50e-06 | 4 | 180 | 3 | PF09324 | |
| Domain | DCB | 3.50e-06 | 4 | 180 | 3 | PF16213 | |
| Domain | ATPase_P-typ_cyto_domN | 2.02e-05 | 35 | 180 | 5 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.33e-05 | 36 | 180 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 2.33e-05 | 36 | 180 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.33e-05 | 36 | 180 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.67e-05 | 37 | 180 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.67e-05 | 37 | 180 | 5 | PF00122 | |
| Domain | Prot_kinase_dom | IRAK2 MELK NEK5 STK39 OXSR1 DMPK NTRK3 ROR1 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 RIOK2 | 8.17e-05 | 489 | 180 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | IRAK2 MELK NEK5 STK39 OXSR1 DMPK NTRK3 ROR1 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 RIOK2 | 8.95e-05 | 493 | 180 | 15 | PS50011 |
| Domain | Endosulphine | 9.24e-05 | 2 | 180 | 2 | IPR006760 | |
| Domain | Sec15 | 9.24e-05 | 2 | 180 | 2 | PF04091 | |
| Domain | EXOC6/Sec15 | 9.24e-05 | 2 | 180 | 2 | IPR007225 | |
| Domain | ATP2B1/4 | 9.24e-05 | 2 | 180 | 2 | IPR030319 | |
| Domain | Endosulfine | 9.24e-05 | 2 | 180 | 2 | PF04667 | |
| Domain | PROTEIN_KINASE_ATP | IRAK2 MELK NEK5 STK39 OXSR1 DMPK NTRK3 ROR1 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 | 1.50e-04 | 459 | 180 | 14 | PS00107 |
| Domain | AGC-kinase_C | 2.02e-04 | 56 | 180 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.02e-04 | 56 | 180 | 5 | PS51285 | |
| Domain | S_TK_X | 2.02e-04 | 56 | 180 | 5 | SM00133 | |
| Domain | P-loop_NTPase | KIF1A SRP54 MCM2 ABCA10 ZRANB3 ABCB1 ABCB4 NWD2 ASPM KIF5B KIF5C DNAH6 DYNC1H1 MPP2 DHX57 RECQL DDX55 ARL4C PALS2 YME1L1 | 2.04e-04 | 848 | 180 | 20 | IPR027417 |
| Domain | Kinase-like_dom | IRAK2 MELK NEK5 STK39 OXSR1 DMPK NTRK3 ROR1 CIT GRK1 LATS1 TIE1 HASPIN ROCK1 RIOK2 | 2.51e-04 | 542 | 180 | 15 | IPR011009 |
| Domain | ROR_rcpt | 2.75e-04 | 3 | 180 | 2 | IPR003079 | |
| Domain | Ryanodine_rcpt | 2.75e-04 | 3 | 180 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.75e-04 | 3 | 180 | 2 | IPR009460 | |
| Domain | RyR | 2.75e-04 | 3 | 180 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.75e-04 | 3 | 180 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.75e-04 | 3 | 180 | 2 | IPR013333 | |
| Domain | PDZ | 4.39e-04 | 141 | 180 | 7 | PF00595 | |
| Domain | SEC7 | 4.49e-04 | 16 | 180 | 3 | PS50190 | |
| Domain | Sec7 | 4.49e-04 | 16 | 180 | 3 | SM00222 | |
| Domain | Sec7_dom | 4.49e-04 | 16 | 180 | 3 | IPR000904 | |
| Domain | AAA | 4.98e-04 | 144 | 180 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 4.98e-04 | 144 | 180 | 7 | IPR003593 | |
| Domain | V-SNARE | 5.47e-04 | 4 | 180 | 2 | PF05008 | |
| Domain | Sec7_N | 5.47e-04 | 4 | 180 | 2 | IPR032691 | |
| Domain | Sec7_N | 5.47e-04 | 4 | 180 | 2 | PF12783 | |
| Domain | Vesicle_trsprt_v-SNARE_N | 5.47e-04 | 4 | 180 | 2 | IPR007705 | |
| Domain | PDZ | 5.87e-04 | 148 | 180 | 7 | SM00228 | |
| Domain | - | 6.36e-04 | 150 | 180 | 7 | 2.30.42.10 | |
| Domain | aa-tRNA-synth_II | 6.46e-04 | 18 | 180 | 3 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 6.46e-04 | 18 | 180 | 3 | PS50862 | |
| Domain | PDZ | 6.61e-04 | 151 | 180 | 7 | PS50106 | |
| Domain | PDZ | 6.88e-04 | 152 | 180 | 7 | IPR001478 | |
| Domain | Pkinase_C | 7.02e-04 | 42 | 180 | 4 | PF00433 | |
| Domain | Ser/Thr_kinase_AS | IRAK2 MELK NEK5 STK39 OXSR1 DMPK CIT GRK1 LATS1 HASPIN ROCK1 | 7.11e-04 | 357 | 180 | 11 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | IRAK2 MELK NEK5 STK39 OXSR1 DMPK CIT GRK1 LATS1 HASPIN ROCK1 | 7.97e-04 | 362 | 180 | 11 | PS00108 |
| Domain | HAD-like_dom | 9.96e-04 | 79 | 180 | 5 | IPR023214 | |
| Domain | Protein_kinase_ATP_BS | 1.16e-03 | 379 | 180 | 11 | IPR017441 | |
| Domain | Quino_amine_DH_bsu | 1.18e-03 | 22 | 180 | 3 | IPR011044 | |
| Domain | Pkinase | IRAK2 MELK NEK5 STK39 OXSR1 DMPK CIT GRK1 LATS1 HASPIN ROCK1 | 1.21e-03 | 381 | 180 | 11 | PF00069 |
| Domain | RIH_assoc-dom | 1.35e-03 | 6 | 180 | 2 | IPR013662 | |
| Domain | OSR1_C | 1.35e-03 | 6 | 180 | 2 | PF12202 | |
| Domain | Ins145_P3_rec | 1.35e-03 | 6 | 180 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.35e-03 | 6 | 180 | 2 | PF08454 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.35e-03 | 6 | 180 | 2 | IPR024678 | |
| Domain | RIH_dom | 1.35e-03 | 6 | 180 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.35e-03 | 6 | 180 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.35e-03 | 6 | 180 | 2 | IPR015925 | |
| Domain | - | 1.35e-03 | 6 | 180 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.35e-03 | 6 | 180 | 2 | PF01365 | |
| Domain | PH | 1.54e-03 | 278 | 180 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 1.58e-03 | 279 | 180 | 9 | PS50003 | |
| Domain | PH_domain | 1.62e-03 | 280 | 180 | 9 | IPR001849 | |
| Domain | ARM-type_fold | STAG1 RYR3 XPO5 ASPM ARFGEF2 ARFGEF1 ECPAS ARFGEF3 HEATR6 PPP2R5E | 1.71e-03 | 339 | 180 | 10 | IPR016024 |
| Domain | - | SRP54 MCM2 ABCA10 ZRANB3 ABCB1 ABCB4 NWD2 DNAH6 DYNC1H1 MPP2 DHX57 RECQL DDX55 ARL4C PALS2 YME1L1 | 2.37e-03 | 746 | 180 | 16 | 3.40.50.300 |
| Domain | SEL1 | 2.49e-03 | 8 | 180 | 2 | SM00671 | |
| Domain | S_TKc | 2.59e-03 | 359 | 180 | 10 | SM00220 | |
| Domain | VWF_A | 2.71e-03 | 99 | 180 | 5 | IPR002035 | |
| Domain | PH_dom-like | KIF1A PLEKHG5 PTPN4 PLCL2 PLEKHA5 PARP9 PHLDA1 CIT PREX2 ROCK1 SNTA1 | 2.88e-03 | 426 | 180 | 11 | IPR011993 |
| Domain | Sel1-like | 3.18e-03 | 9 | 180 | 2 | IPR006597 | |
| Domain | MIR | 3.95e-03 | 10 | 180 | 2 | PF02815 | |
| Domain | L27_C | 3.95e-03 | 10 | 180 | 2 | IPR014775 | |
| Domain | MIR_motif | 3.95e-03 | 10 | 180 | 2 | IPR016093 | |
| Domain | L27 | 3.95e-03 | 10 | 180 | 2 | PF02828 | |
| Domain | MIR | 3.95e-03 | 10 | 180 | 2 | PS50919 | |
| Domain | MIR | 3.95e-03 | 10 | 180 | 2 | SM00472 | |
| Domain | Hydrolase_3 | 3.95e-03 | 10 | 180 | 2 | PF08282 | |
| Domain | ARM-like | 4.75e-03 | 270 | 180 | 8 | IPR011989 | |
| Domain | aa-tRNA-synt_IIb | 4.80e-03 | 11 | 180 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 4.80e-03 | 11 | 180 | 2 | PF00587 | |
| Domain | Ion_trans_dom | 4.96e-03 | 114 | 180 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.96e-03 | 114 | 180 | 5 | PF00520 | |
| Domain | Pkinase_C | 5.38e-03 | 37 | 180 | 3 | IPR017892 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.50e-07 | 54 | 137 | 7 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.50e-07 | 54 | 137 | 7 | MM15202 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.98e-06 | 12 | 137 | 4 | M27326 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 5.48e-06 | 27 | 137 | 5 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.62e-06 | 28 | 137 | 5 | M924 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 7.92e-06 | 14 | 137 | 4 | MM15052 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | RYR2 RYR3 ATP2C2 TPCN2 TRPC7 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 8.33e-06 | 176 | 137 | 10 | MM15718 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | RYR2 RYR3 ATP2C2 TPCN2 TRPC7 ATP6V0A4 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.17e-05 | 183 | 137 | 10 | M997 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.89e-05 | 130 | 137 | 8 | M27454 | |
| Pathway | KEGG_AMINOACYL_TRNA_BIOSYNTHESIS | 4.56e-05 | 41 | 137 | 5 | M14691 | |
| Pathway | REACTOME_TRNA_AMINOACYLATION | 5.13e-05 | 42 | 137 | 5 | M456 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 6.40e-05 | 103 | 137 | 7 | MM15196 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 9.45e-05 | 76 | 137 | 6 | MM15051 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.88e-04 | 86 | 137 | 6 | M916 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.90e-04 | 55 | 137 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.25e-04 | 57 | 137 | 5 | MM15643 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA10 RYR2 RYR3 ABCB1 ABCB4 SLC38A1 ATP2C2 SEL1L SLC12A6 TPCN2 TRPC7 SLC5A4 ATP6V0A4 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 2.74e-04 | 736 | 137 | 18 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | RYR2 RYR3 ABCB1 ABCB4 SLC38A1 ATP2C2 SEL1L SLC12A6 TPCN2 TRPC7 SLC5A4 ATP6V0A4 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 3.24e-04 | 681 | 137 | 17 | MM14985 |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 3.95e-04 | 36 | 137 | 4 | M39831 | |
| Pubmed | 1.49e-13 | 21 | 193 | 8 | 12216073 | ||
| Pubmed | HSP90B1 HTRA1 ERC1 MATR3 RPS10 TSG101 PLEKHG5 DIP2A NWD2 KARS1 SARS1 PLEKHA5 LRRC7 KIF5B KIF5C FGG DNAH6 HSPA9 DYNC1H1 MPP2 SLC12A6 WARS1 DSP ARFGEF2 DHX57 CIT PRPF40A PPP2R5E ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 7.41e-13 | 1431 | 193 | 34 | 37142655 | |
| Pubmed | 2.24e-12 | 9 | 193 | 6 | 14611804 | ||
| Pubmed | HSP90B1 MATR3 ITGA4 PARP4 KARS1 SARS1 XPO5 DYNC1H1 SEL1L DSP ARFGEF2 ARFGEF1 RECQL VTI1A HARS2 PPP2R5E CTNNA3 CEP57 ATP2B1 | 1.33e-11 | 457 | 193 | 19 | 22190034 | |
| Pubmed | SCN11A HSP90B1 STAG1 ERC1 MATR3 PDAP1 RYR2 ABCB1 ABCB4 COG1 ASPM PKHD1 KIF5B KIF5C HSD17B4 DNAH6 HSPA9 SLC12A6 DSP IFT81 DHX57 DDX55 LATS1 IFT88 KIAA0825 CEP57 ATP2B1 ATP2B2 ATP2B3 SLC25A31 ATP5F1C | 1.06e-10 | 1442 | 193 | 31 | 35575683 | |
| Pubmed | HSP90B1 STAG1 KIF1A ERC1 ZMYND8 TSG101 RYR3 DIP2A COG1 GEMIN8 KIF5C HSD17B4 MGAT5B HSPA9 DYNC1H1 WARS1 DSP PPFIBP1 IFT81 ARFGEF2 SKIL CIT HEATR6 PPP2R5E IFT88 RORB PALS2 YME1L1 SNTA1 | 1.48e-10 | 1285 | 193 | 29 | 35914814 | |
| Pubmed | 2.76e-10 | 8 | 193 | 5 | 12007189 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCP110 ERC1 STYXL2 MCM2 TSG101 MELK PPM1H KARS1 XPO5 NEK5 CXCR4 NAF1 RTL9 PLCL2 EXOC6B PAN2 PLEKHA5 KIF5C DYNC1H1 VTI1B EXOC6 DNAAF4 PPFIBP1 IFT81 PPP2R5E IFT88 TTC21B YME1L1 ATP2B2 | 2.81e-10 | 1321 | 193 | 29 | 27173435 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90B1 KIF1A MATR3 RPS10 MCM2 TSG101 SLC38A1 KARS1 SARS1 XPO5 CXCR4 SERPINB12 KIF5B HSD17B4 HSPA9 DYNC1H1 WARS1 DSP RECQL NOL9 ECPAS DDX55 PRPF40A POLR3A SNW1 UTP4 MTR ATP2B1 ATP2B3 ATP5F1C | 3.60e-10 | 1425 | 193 | 30 | 30948266 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 9.19e-10 | 4 | 193 | 4 | 12209837 | |
| Pubmed | 9.19e-10 | 4 | 193 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 9.19e-10 | 4 | 193 | 4 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 9.19e-10 | 4 | 193 | 4 | 7989379 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 9.19e-10 | 4 | 193 | 4 | 36130203 | |
| Pubmed | 9.19e-10 | 4 | 193 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 9.19e-10 | 4 | 193 | 4 | 8634322 | |
| Pubmed | 9.19e-10 | 4 | 193 | 4 | 12784250 | ||
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 9.19e-10 | 4 | 193 | 4 | 11152753 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 9.19e-10 | 4 | 193 | 4 | 10434059 | |
| Pubmed | 9.19e-10 | 4 | 193 | 4 | 15101689 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.59e-09 | 38 | 193 | 7 | 30786075 | |
| Pubmed | 4.58e-09 | 5 | 193 | 4 | 17938178 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSP90B1 ERC1 MATR3 RPS10 MCM2 KARS1 LRRC7 KIF5B KIF5C DNAH6 HSPA9 DYNC1H1 DSP CIT PRPF40A POLR3A HARS2 ROCK1 ATP2B1 ATP2B4 ATP5F1C | 1.26e-08 | 847 | 193 | 21 | 35235311 |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.37e-08 | 6 | 193 | 4 | 12767889 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSP90B1 MATR3 RPS10 SRP54 MCM2 MCM10 MELK KARS1 SERPINB12 ASPM PLEKHA5 KIF5B HSPA9 DYNC1H1 WARS1 DSP DHX57 RECQL NOL9 POLR3A SNW1 UTP4 RIOK2 ATP2B1 YME1L1 ATP5F1C | 3.82e-08 | 1353 | 193 | 26 | 29467282 |
| Pubmed | 6.32e-08 | 8 | 193 | 4 | 10951186 | ||
| Pubmed | HSP90B1 ERC1 PDAP1 SLC38A1 XPO5 PLEKHA5 LRRC7 KIF5B HSPA9 DYNC1H1 DSP PPFIBP1 ECPAS PRPF40A LATS1 ROCK1 ATP2B1 ATP5F1C | 1.01e-07 | 708 | 193 | 18 | 39231216 | |
| Pubmed | ARPP19 ATP2C2 STK39 OXSR1 DMPK MMP12 TAF1L SEC23B CAPN3 SUV39H2 POLR3A GRK1 HARS2 PPP2R5E LATS1 ATP2B1 ATP2B4 ENSA | 1.58e-07 | 730 | 193 | 18 | 34857952 | |
| Pubmed | KIF1A RPS10 KARS1 XPO5 KIF5B HSPA9 DYNC1H1 SEC23B WARS1 DSP DHX57 RECQL NOL9 ECPAS PRPF40A SNW1 UTP4 | 1.67e-07 | 653 | 193 | 17 | 22586326 | |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 1.68e-07 | 3 | 193 | 3 | 24645645 | |
| Pubmed | 4.39e-07 | 12 | 193 | 4 | 14557543 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | HSP90B1 KIF1A ERC1 RPS10 BRCA2 LRRC7 KIF5B KIF5C HSPA9 DYNC1H1 MPP2 SLC12A6 SASH1 ROCK1 ATP2B2 ATP5F1C | 4.47e-07 | 621 | 193 | 16 | 22794259 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | STAG1 RPS10 ZMYND8 SRP54 MCM2 KARS1 KIF5B OXSR1 KIF5C DYNC1H1 SEC23B WARS1 RECQL POLR3A UTP4 YME1L1 ATP5F1C | 4.75e-07 | 704 | 193 | 17 | 29955894 |
| Pubmed | 5.32e-07 | 29 | 193 | 5 | 15071553 | ||
| Pubmed | HSP90B1 MATR3 RPS10 ITGA4 MELK PARP4 PLEKHA5 PARP9 KIF5B DYNC1H1 ARFGEF2 RECQL NOL9 ECPAS DDX55 CIT PRPF40A POLR3A ATP2B1 YME1L1 ATP2B4 ATP5F1C | 6.48e-07 | 1168 | 193 | 22 | 19946888 | |
| Pubmed | Expressions of cancer-testis antigens in human hepatocellular carcinomas. | 6.70e-07 | 4 | 193 | 3 | 11179834 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.70e-07 | 4 | 193 | 3 | 10469592 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 16735509 | ||
| Pubmed | Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. | 6.70e-07 | 4 | 193 | 3 | 10749136 | |
| Pubmed | Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. | 6.70e-07 | 4 | 193 | 3 | 12037676 | |
| Pubmed | Molecular mechanisms underlying human synovial sarcoma development. | 6.70e-07 | 4 | 193 | 3 | 11107170 | |
| Pubmed | 9.37e-07 | 183 | 193 | 9 | 23956138 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.89e-07 | 94 | 193 | 7 | 21542922 | |
| Pubmed | 1.34e-06 | 191 | 193 | 9 | 20195357 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KIF1A EARS2 ERC1 KARS1 SARS1 XPO5 COG1 KIF5B DYNC1H1 VTI1B SEL1L EXOC6 ARFGEF1 ECPAS ARFGEF3 PPP2R5E MTR YME1L1 ATP2B4 | 1.46e-06 | 942 | 193 | 19 | 31073040 |
| Pubmed | Sites of regulated phosphorylation that control K-Cl cotransporter activity. | 1.67e-06 | 5 | 193 | 3 | 19665974 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.67e-06 | 5 | 193 | 3 | 12629516 | |
| Pubmed | SSX: a multigene family with several members transcribed in normal testis and human cancer. | 1.67e-06 | 5 | 193 | 3 | 9378559 | |
| Pubmed | 1.79e-06 | 147 | 193 | 8 | 16959763 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSP90B1 HEBP2 ERC1 MATR3 RPS10 PDAP1 MCM2 KARS1 SARS1 XPO5 GEMIN8 KIF5B HSPA9 DYNC1H1 WARS1 DSP RECQL NOL9 ECPAS PRPF40A ENSA | 1.90e-06 | 1149 | 193 | 21 | 35446349 |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 12763866 | ||
| Pubmed | MATR3 ZMYND8 TSG101 INTS14 XPO5 HSPA9 DYNC1H1 SEL1L IFT81 NOL9 ECPAS PPP2R5E UTP4 ATP5F1C | 3.39e-06 | 560 | 193 | 14 | 35241646 | |
| Pubmed | CCP110 ERC1 RPS10 PDAP1 SRP54 MCM10 KARS1 KIF5B IFT81 RECQL CBX4 DDX55 MED25 ROCK1 ATP5F1C | 3.63e-06 | 645 | 193 | 15 | 25281560 | |
| Pubmed | HSP90B1 ERC1 MATR3 MCM2 PARP4 KARS1 KIF5B HSPA9 SEC23B DSP ARFGEF2 ARFGEF1 ECPAS | 4.42e-06 | 494 | 193 | 13 | 26831064 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSP90B1 STAG1 SRP54 MELK PARP4 XPO5 OXSR1 DYNC1H1 SEC23B MPP2 DSP ARFGEF2 PRPF40A SNW1 | 5.27e-06 | 582 | 193 | 14 | 20467437 |
| Pubmed | HSP90B1 ERC1 SLC6A17 KARS1 BRCA2 XPO5 COG1 DYNC1H1 SEL1L WARS1 DSP VTI1A NOL9 ECPAS YME1L1 ATP5F1C | 5.44e-06 | 754 | 193 | 16 | 35906200 | |
| Pubmed | Stable kinesin and dynein assemblies drive the axonal transport of mammalian prion protein vesicles. | 5.79e-06 | 7 | 193 | 3 | 21335237 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 29162624 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 17312020 | ||
| Pubmed | 6.22e-06 | 22 | 193 | 4 | 17893145 | ||
| Pubmed | HTRA1 STAG1 ZMYND8 RYR2 XPO5 PLCL2 DYNC1H1 SASH1 ARFGEF2 CBX4 SKIL PRPF40A PPP2R5E ROCK1 | 6.27e-06 | 591 | 193 | 14 | 15231748 | |
| Pubmed | HSP90B1 MCM2 SLC38A1 COG1 HSD17B4 HSPA9 SEC23B VTI1B SLC12A6 DNAJC25 PPFIBP1 ARFGEF2 ARFGEF1 UTP4 PALS2 ATP2B1 ATP2B4 ATP5F1C | 6.79e-06 | 952 | 193 | 18 | 38569033 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 ERC1 MATR3 MELK PPM1H PLEKHA5 KIF5B KIF5C SEC23B SASH1 DSP PPFIBP1 NTRK3 CBX4 ARFGEF3 LATS1 ATP2B1 | 7.07e-06 | 861 | 193 | 17 | 36931259 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSP90B1 ERC1 MATR3 RPS10 ITGA4 KARS1 SERPINB12 PLEKHA5 KIF5B HSPA9 DYNC1H1 DSP PPFIBP1 RECQL NOL9 DDX55 CIT HARS2 SNW1 UTP4 ATP5F1C | 7.59e-06 | 1257 | 193 | 21 | 36526897 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 9.08e-06 | 183 | 193 | 8 | 31932471 | |
| Pubmed | EARS2 MATR3 MCM2 PLEKHG5 MELK KARS1 PAN2 PLEKHA5 OXSR1 SASH1 ECPAS DDX55 CEP57 | 9.18e-06 | 529 | 193 | 13 | 14621295 | |
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 9.23e-06 | 8 | 193 | 3 | 24393035 | |
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 12386165 | ||
| Pubmed | HSP90B1 EARS2 RPS10 SRP54 DIP2A SARS1 UBE2G2 GEMIN8 ASPM PLEKHA5 HSPA9 DNAJC25 PPFIBP1 IFT81 NOL9 PRPF40A SNW1 UTP4 MTR ATP2B1 YME1L1 ATP2B4 ENSA | 9.51e-06 | 1487 | 193 | 23 | 33957083 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HSP90B1 EARS2 SRP54 TSG101 KARS1 SARS1 OXSR1 HSPA9 WARS1 HARS2 PPP2R5E SNW1 PALS2 CEP57 YME1L1 | 1.03e-05 | 704 | 193 | 15 | 32994395 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSP90B1 MATR3 RPS10 ZMYND8 PDAP1 SRP54 TSG101 NWD2 KARS1 PAN2 HSD17B4 DYNC1H1 SEC23B DSP DHX57 CBX4 DDX55 PRPF40A SNW1 | 1.06e-05 | 1082 | 193 | 19 | 38697112 |
| Pubmed | HSP90B1 MATR3 RPS10 ZMYND8 SRP54 INTS14 KARS1 KIF5B KIF5C HSD17B4 HSPA9 DYNC1H1 DSP ECPAS PRPF40A SNW1 | 1.30e-05 | 809 | 193 | 16 | 32129710 | |
| Pubmed | The small GTPase RSG1 controls a final step in primary cilia initiation. | 1.70e-05 | 28 | 193 | 4 | 29038301 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.73e-05 | 262 | 193 | 9 | 36880596 | |
| Pubmed | DIP2A PARP4 PLEKHA5 HSD17B4 SEC23B PPFIBP1 DHX57 NOL9 DDX55 POLR3A MTR RIOK2 CMTR2 ATP5F1C | 1.81e-05 | 650 | 193 | 14 | 38777146 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.86e-05 | 202 | 193 | 8 | 33005030 | |
| Pubmed | HSP90B1 TSG101 ABCB1 SLC38A1 HSPA9 DYNC1H1 SEC23B SLC12A6 RECQL NOL9 PALS2 ATP5F1C | 1.87e-05 | 484 | 193 | 12 | 31995728 | |
| Pubmed | 1.96e-05 | 10 | 193 | 3 | 12970426 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CCP110 ERC1 SRP54 PLEKHA5 GCC1 HSD17B4 FAM162A SEL1L PPFIBP1 ECPAS CIT HEATR6 LATS1 ATP2B1 ATP2B4 | 2.28e-05 | 754 | 193 | 15 | 33060197 |
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 2.47e-05 | 103 | 193 | 6 | 22623531 | |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | SRP54 ASPM HSPA9 SEC23B POLR3A SNW1 UTP4 CEP57 YME1L1 BRF2 ATP5F1C | 2.49e-05 | 419 | 193 | 11 | 28700943 |
| Pubmed | MCM2 ITGA4 SLC38A1 PLEKHA5 SLC12A6 SASH1 PPFIBP1 ROCK1 PALS2 ATP2B1 ATP2B4 | 2.60e-05 | 421 | 193 | 11 | 36976175 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPS10 PDAP1 SRP54 KARS1 SERPINB12 STK39 PARP9 KIF5B OXSR1 HSD17B4 HSPA9 DSP ARFGEF1 RECQL NOL9 ECPAS PRPF40A HEATR6 SNW1 ROCK1 ENSA | 2.63e-05 | 1367 | 193 | 21 | 32687490 |
| Pubmed | 2.93e-05 | 32 | 193 | 4 | 12493773 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10488067 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 18200497 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 3.06e-05 | 2 | 193 | 2 | 21705081 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 3.06e-05 | 2 | 193 | 2 | 9196326 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 18657858 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 24655550 | ||
| Pubmed | Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals. | 3.06e-05 | 2 | 193 | 2 | 24191005 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 8898203 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 2473069 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19185004 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 8898078 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 25349153 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 14550562 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10716990 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19828640 | ||
| Interaction | KCTD13 interactions | HSP90B1 HTRA1 ERC1 MATR3 RPS10 TSG101 PLEKHG5 DIP2A NWD2 KARS1 SARS1 PLEKHA5 LRRC7 KIF5B KIF5C FGG DNAH6 HSPA9 DYNC1H1 MPP2 SLC12A6 WARS1 DSP ARFGEF2 DHX57 CIT PRPF40A PPP2R5E ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 ATP5F1C | 2.77e-07 | 1394 | 190 | 34 | int:KCTD13 |
| Interaction | NPTN interactions | STAG1 EARS2 XPO5 COG1 EXOC6 ARFGEF2 ARFGEF1 ECPAS ARFGEF3 HEATR6 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.19e-07 | 278 | 190 | 14 | int:NPTN |
| Interaction | C3orf18 interactions | COG1 EXOC6B EXOC6 ARFGEF2 ECPAS PPP2R5E ATP2B2 ATP2B3 ATP2B4 | 1.45e-06 | 115 | 190 | 9 | int:C3orf18 |
| Interaction | C17orf78 interactions | 3.57e-06 | 12 | 190 | 4 | int:C17orf78 | |
| Interaction | CALM1 interactions | CCP110 HSP90B1 STAG1 KIF1A MATR3 MCM2 RYR2 ASPM PAN2 PLEKHA5 DNAAF4 CIT GRK1 SNW1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SNTA1 | 7.81e-06 | 626 | 190 | 19 | int:CALM1 |
| Interaction | HSD17B6 interactions | 9.63e-06 | 15 | 190 | 4 | int:HSD17B6 | |
| Interaction | FTL interactions | CCP110 KIF1A ERC1 MCM10 MELK ZRANB3 NEK5 ASPM PLEKHA5 PGBD2 POLR3A PALS2 CEP57 | 2.77e-05 | 348 | 190 | 13 | int:FTL |
| Interaction | HARS1 interactions | 2.77e-05 | 127 | 190 | 8 | int:HARS1 | |
| Interaction | OPALIN interactions | DIP2A XPO5 ARFGEF2 ARFGEF1 ECPAS HEATR6 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.05e-05 | 209 | 190 | 10 | int:OPALIN |
| Interaction | HAX1 interactions | ABCB1 ABCB4 SARS1 GEMIN8 HSPA9 DNAJC25 NTRK3 ARFGEF2 NOL9 POLR3A HEATR6 LATS1 MTR YME1L1 | 3.11e-05 | 404 | 190 | 14 | int:HAX1 |
| Interaction | CYP2B6 interactions | 4.46e-05 | 8 | 190 | 3 | int:CYP2B6 | |
| Interaction | AKAP9 interactions | 4.90e-05 | 221 | 190 | 10 | int:AKAP9 | |
| Interaction | HRAS interactions | IRAK2 ITGA4 SLC38A1 SARS1 XPO5 PLEKHA5 GCC1 PLAAT4 PHLDA1 PPFIBP1 NTRK3 ROR1 ARFGEF2 ARFGEF1 ECPAS HEATR6 ROCK1 ATP2B1 ATP2B4 | 5.86e-05 | 725 | 190 | 19 | int:HRAS |
| Interaction | PPP2R1A interactions | ARPP19 RPS10 MCM2 ITGA4 STRIP2 INTS14 PLEKHA5 KIF5B HSPA9 DYNC1H1 WARS1 PPFIBP1 CIT POLR3A PPP2R5E SNW1 RORC ENSA | 6.13e-05 | 665 | 190 | 18 | int:PPP2R1A |
| Interaction | SSX2 interactions | 6.36e-05 | 45 | 190 | 5 | int:SSX2 | |
| Interaction | PTGES3 interactions | HSP90B1 KIF1A MCM2 MELK ZRANB3 DIP2A INTS14 SARS1 BRCA2 MPP2 NOL9 DDX55 POLR3A MED25 | 7.24e-05 | 437 | 190 | 14 | int:PTGES3 |
| Interaction | FPR1 interactions | 7.86e-05 | 147 | 190 | 8 | int:FPR1 | |
| Interaction | SPACA1 interactions | 8.81e-05 | 111 | 190 | 7 | int:SPACA1 | |
| Interaction | BSG interactions | HSP90B1 EARS2 KARS1 UBE2G2 COG1 FAM162A SEL1L SLC12A6 NTRK3 ARFGEF2 ARFGEF1 ECPAS HEATR6 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.05e-04 | 631 | 190 | 17 | int:BSG |
| Interaction | DNAJB8 interactions | 1.09e-04 | 80 | 190 | 6 | int:DNAJB8 | |
| Cytoband | Xp11.23 | 3.16e-06 | 95 | 192 | 6 | Xp11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 2.05e-04 | 377 | 192 | 8 | chrXp11 | |
| GeneFamily | ATPases Ca2+ transporting | 1.66e-09 | 9 | 123 | 5 | 1209 | |
| GeneFamily | PDZ domain containing | 8.13e-05 | 152 | 123 | 7 | 1220 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.37e-04 | 3 | 123 | 2 | 287 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 2.75e-04 | 19 | 123 | 3 | 132 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 5.60e-04 | 24 | 123 | 3 | 615 | |
| GeneFamily | Exocyst complex | 1.60e-03 | 9 | 123 | 2 | 1055 | |
| GeneFamily | ATP binding cassette subfamily B | 2.43e-03 | 11 | 123 | 2 | 806 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.53e-03 | 40 | 123 | 3 | 321 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.77e-03 | 46 | 123 | 3 | 622 | |
| GeneFamily | SNAREs|BCL2 homology region 3 (BH3) only | 4.55e-03 | 15 | 123 | 2 | 1124 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | STAG1 MATR3 IRAK2 MCM2 MELK SLC38A1 BRCA2 ASPM KIF5B HSPA9 SEL1L WARS1 ROR1 ARFGEF2 RECQL PRPF40A ARL4C RIOK2 CEP57 ATP2B1 | 2.31e-07 | 721 | 186 | 20 | M10237 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ARPP19 KIF1A SLC6A17 MATR3 SARS1 STMN3 PLCL2 PAN2 NKX2-2 KIF5B KIF5C HSPA9 DYNC1H1 WARS1 DSP ROR1 ARFGEF2 CBX4 ECPAS ROCK1 PALS2 YME1L1 | 1.10e-06 | 946 | 186 | 22 | M39169 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | STAG1 EARS2 MATR3 SRP54 MCM2 MCM10 SSX2 MELK ZRANB3 UBE2G2 BRCA2 XPO5 ASPM KIF5B HSPA9 FAM162A ROR1 SUV39H2 PRPF40A ARL4C PPP2R5E SNW1 UTP4 PALS2 YME1L1 BRF2 | 1.59e-06 | 1290 | 186 | 26 | M80 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | KIF1A MATR3 ZMYND8 ITGA4 SSX4 RYR3 ABCB1 ABCB4 SLC38A1 KARS1 PLCL2 OXSR1 DYNC1H1 SEC23B SEL1L ARFGEF2 NOL9 ECPAS PPP2R5E MTR ROCK1 CEP57 ENSA ATP5F1C | 5.84e-06 | 1215 | 186 | 24 | M41122 |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 | 6.92e-06 | 6 | 186 | 3 | M5931 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | PLBD1 SCN11A SSX7 UBE2G2 SERPINB12 RTL9 KIF5C SLC12A6 GSDMC CTNNA3 ANGPTL5 | 7.77e-06 | 290 | 186 | 11 | M11616 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STAG1 ERC1 ZMYND8 MELK PTPN4 BRCA2 STK39 OXSR1 KIF5C SASH1 ROR1 ARFGEF1 PPP2R5E SNW1 MTR ROCK1 PALS2 ATP2B1 ATP2B4 | 1.20e-05 | 856 | 186 | 19 | M4500 |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP | 1.38e-05 | 200 | 186 | 9 | M9278 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | ARPP19 MCM10 MELK SLC38A1 BRCA2 ASPM MMP12 WARS1 DSP ARFGEF2 RECQL ATP2B1 YME1L1 | 2.58e-05 | 458 | 186 | 13 | M8520 |
| Coexpression | GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN | 3.74e-05 | 175 | 186 | 8 | M7101 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP | 4.20e-05 | 89 | 186 | 6 | M2761 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | CCP110 HSP90B1 MATR3 MCM10 MELK BRCA2 STMN3 ASPM PAN2 RECQL CIT KIAA0825 HASPIN CTNNA3 CEP57 YME1L1 | 5.38e-05 | 714 | 186 | 16 | M1744 |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 9.57e-05 | 200 | 186 | 8 | M4889 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN | 9.57e-05 | 200 | 186 | 8 | M3839 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN | 9.57e-05 | 200 | 186 | 8 | M6039 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 9.57e-05 | 200 | 186 | 8 | M3893 | |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP | 9.57e-05 | 200 | 186 | 8 | M6269 | |
| Coexpression | GOLDRATH_HOMEOSTATIC_PROLIFERATION | 1.01e-04 | 150 | 186 | 7 | M3592 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN | 1.24e-04 | 155 | 186 | 7 | M6675 | |
| Coexpression | GOLDRATH_HOMEOSTATIC_PROLIFERATION | 1.35e-04 | 157 | 186 | 7 | MM613 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | PDAP1 BRCA2 COG1 ASPM KIF5B NAA16 ECPAS CIT PRPF40A PREX2 SNW1 ROCK1 PALS2 RIOK2 CEP57 YME1L1 | 3.04e-06 | 469 | 182 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | PPM1H SLC38A1 ATP2C2 PKHD1 C5 KIF5C RFX6 OPRD1 ARFGEF3 CTNNA3 | 6.18e-09 | 184 | 187 | 10 | fa4915b0498f3069fd5ef497286445528f75187e |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | FSTL5 PPM1H SLC38A1 ATP2C2 PKHD1 KIF5C DSP RFX6 ARFGEF3 CTNNA3 | 1.03e-08 | 194 | 187 | 10 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ANKRD36C ABCB1 PRDM1 SLC38A1 DIP2A PTPN4 CXCR4 STK39 PLAAT4 ARL4C | 1.25e-08 | 198 | 187 | 10 | 58d805e827299292750b09c6283fdbe406b75f79 |
| ToppCell | mild-MAIT|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ABCB1 PRDM1 SLC38A1 PTPN4 CXCR4 PLEKHA5 KIF5C ARL4C RORC SNTA1 | 1.37e-08 | 200 | 187 | 10 | 1e3ef15ce48b9a19a6ac3e08ea0234a9376e6596 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-07 | 187 | 187 | 9 | f1ba41f2ec703251a81c46e08d45e70210f298e7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-07 | 189 | 187 | 9 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-07 | 189 | 187 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.28e-07 | 192 | 187 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | ANKRD36C ABCB1 PRDM1 SLC38A1 PTPN4 CXCR4 PLAAT4 ARL4C ATP2B4 | 1.40e-07 | 194 | 187 | 9 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.67e-07 | 198 | 187 | 9 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-07 | 200 | 187 | 9 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | severe-MAIT|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-07 | 200 | 187 | 9 | 1daf43f1bdd49585dce5e957820554d7f3c1bd4a | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-MAIT|Int-URO / Disease, condition lineage and cell class | 1.81e-07 | 200 | 187 | 9 | 043c18e79a969e37bbff86443e553ac09fe33f84 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-07 | 200 | 187 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | severe-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-07 | 200 | 187 | 9 | 8a849d0ef244aa2666da2d31bd0731fb04e40911 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 3.80e-07 | 159 | 187 | 8 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.52e-07 | 167 | 187 | 8 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 6.61e-07 | 171 | 187 | 8 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.21e-07 | 176 | 187 | 8 | 9a4cef3dc88f64a71b91ab4790ea19334afee3ee | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-07 | 180 | 187 | 8 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 1.06e-06 | 182 | 187 | 8 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-06 | 182 | 187 | 8 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-06 | 182 | 187 | 8 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-06 | 182 | 187 | 8 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-06 | 182 | 187 | 8 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 186 | 187 | 8 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 188 | 187 | 8 | f8e6247bedc0ba494c5bb551539cb8ba5a97f557 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-06 | 188 | 187 | 8 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 188 | 187 | 8 | 8155bc5476fc333bedcc78c5ddcc8e4912536caa | |
| ToppCell | NS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-06 | 189 | 187 | 8 | fb7572fb4c7c43886d57a025decad076f32a14c4 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.46e-06 | 190 | 187 | 8 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-MAIT|COVID-19_Mild / Disease group, lineage and cell class | 1.58e-06 | 192 | 187 | 8 | d47bd132e57f5b4bddcf3dfa399cee149eca7e44 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.58e-06 | 192 | 187 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-06 | 194 | 187 | 8 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-06 | 194 | 187 | 8 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.77e-06 | 195 | 187 | 8 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-06 | 197 | 187 | 8 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-06 | 197 | 187 | 8 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-06 | 197 | 187 | 8 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.91e-06 | 197 | 187 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-06 | 197 | 187 | 8 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-06 | 198 | 187 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.06e-06 | 199 | 187 | 8 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-06 | 199 | 187 | 8 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-MAIT|COVID-19_Severe / Disease, condition lineage and cell class | 2.14e-06 | 200 | 187 | 8 | b8cfccecff9900aee323c40e771c94e560b8c488 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 2.14e-06 | 200 | 187 | 8 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 187 | 8 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-MAIT|COVID-19_Mild / Disease, condition lineage and cell class | 2.14e-06 | 200 | 187 | 8 | 45b2a84d5a325f551205ae31c164d2de7773d3b6 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 2.14e-06 | 200 | 187 | 8 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.14e-06 | 200 | 187 | 8 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.65e-06 | 166 | 187 | 7 | a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.48e-06 | 169 | 187 | 7 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 170 | 187 | 7 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 8.39e-06 | 172 | 187 | 7 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 8.72e-06 | 173 | 187 | 7 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 9.05e-06 | 174 | 187 | 7 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 9.39e-06 | 175 | 187 | 7 | f6663e5a9c87e27f3459a6481768b03aff7d0855 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 9.75e-06 | 176 | 187 | 7 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 177 | 187 | 7 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / Disease condition and Cell class | 1.01e-05 | 177 | 187 | 7 | 8eb69041f482b58325e3539f607923f7b1fa5977 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 177 | 187 | 7 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 179 | 187 | 7 | e520eadde4f1b7fb868dbbe94c4d62b3776c55eb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 180 | 187 | 7 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 180 | 187 | 7 | 05f14cd367021891166825a8aac171227e2bcd97 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 181 | 187 | 7 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 1.17e-05 | 120 | 187 | 6 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.21e-05 | 182 | 187 | 7 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.21e-05 | 182 | 187 | 7 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 182 | 187 | 7 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | Healthy_donor-MAIT|Healthy_donor / disease group, cell group and cell class (v2) | 1.21e-05 | 182 | 187 | 7 | ac7c83464487ecde3df6804a99551307bd768f21 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 183 | 187 | 7 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.26e-05 | 183 | 187 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 184 | 187 | 7 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.30e-05 | 184 | 187 | 7 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.30e-05 | 184 | 187 | 7 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-05 | 185 | 187 | 7 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 186 | 187 | 7 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 187 | 187 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 1.44e-05 | 187 | 187 | 7 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 188 | 187 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 188 | 187 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 188 | 187 | 7 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | (6)_Macrophage-(60)_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 1.50e-05 | 74 | 187 | 5 | 356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 1.55e-05 | 189 | 187 | 7 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 1.55e-05 | 189 | 187 | 7 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.55e-05 | 189 | 187 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.55e-05 | 189 | 187 | 7 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.55e-05 | 189 | 187 | 7 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | ASK440-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.55e-05 | 189 | 187 | 7 | 868a387d19eb02bf41933e786b7d23e920a5d433 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 189 | 187 | 7 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.55e-05 | 189 | 187 | 7 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-05 | 190 | 187 | 7 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 190 | 187 | 7 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 190 | 187 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.60e-05 | 190 | 187 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 190 | 187 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 190 | 187 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.60e-05 | 190 | 187 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 127 | 187 | 6 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 191 | 187 | 7 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| Drug | p-hydroxyhippuric acid | 8.05e-10 | 14 | 187 | 6 | CID000151012 | |
| Drug | AC1L1IZE | KIF1A RYR2 RYR3 KARS1 ATP2C2 DYNC1H1 RORC ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 8.96e-10 | 131 | 187 | 12 | CID000004799 |
| Drug | AC1L88YH | 3.25e-09 | 17 | 187 | 6 | CID000374551 | |
| Drug | 1sqc | 8.63e-09 | 10 | 187 | 5 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 1.57e-08 | 11 | 187 | 5 | CID000008718 | |
| Drug | mag-fura-2 | 1.88e-08 | 37 | 187 | 7 | CID000123839 | |
| Drug | 1vyq | 2.68e-08 | 12 | 187 | 5 | CID004369390 | |
| Drug | strontium | 8.65e-08 | 68 | 187 | 8 | CID000104798 | |
| Drug | AC1NSKPI | 4.21e-07 | 57 | 187 | 7 | CID005311482 | |
| Drug | XeC compound | 4.56e-07 | 84 | 187 | 8 | CID000005701 | |
| Drug | fluo-3 | 7.70e-07 | 122 | 187 | 9 | CID000104978 | |
| Drug | AC1L25Y6 | 1.06e-06 | 23 | 187 | 5 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 1.06e-06 | 23 | 187 | 5 | CID000165791 | |
| Drug | tBuBHQ | 1.58e-06 | 69 | 187 | 7 | CID000002374 | |
| Drug | cyhexatin | 1.65e-06 | 25 | 187 | 5 | CID005364545 | |
| Drug | lanthanum | 1.92e-06 | 136 | 187 | 9 | CID000023926 | |
| Drug | agelasine B | 2.02e-06 | 46 | 187 | 6 | CID006439899 | |
| Drug | dodecyl ether | 2.03e-06 | 26 | 187 | 5 | CID000020667 | |
| Drug | Ro 46861 | 2.07e-06 | 12 | 187 | 4 | CID000003128 | |
| Drug | 2d41 | 2.47e-06 | 27 | 187 | 5 | CID009543496 | |
| Drug | clotrimazole | TSG101 ABCB1 ATP2C2 MMP12 SLC12A6 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.90e-06 | 143 | 187 | 9 | CID000002812 |
| Drug | 8-hydroxycoumarin | 2.97e-06 | 13 | 187 | 4 | CID000122783 | |
| Drug | nimodipine | 3.26e-06 | 145 | 187 | 9 | CID000004497 | |
| Drug | octaethylene glycol | 3.58e-06 | 29 | 187 | 5 | CID000078798 | |
| Drug | Bay K 8644 | 4.30e-06 | 150 | 187 | 9 | CID000002303 | |
| Drug | dihydropyridine | RYR2 RYR3 ABCB1 ATP2C2 DMPK TPCN2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.68e-06 | 193 | 187 | 10 | CID000104822 |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | ARPP19 ERC1 WARS1 AOX1 ARFGEF1 SKIL SUV39H2 MED25 ROCK1 BRF2 | 5.61e-06 | 197 | 187 | 10 | 6558_DN |
| Drug | oxalate | 6.58e-06 | 158 | 187 | 9 | CID000000971 | |
| Drug | ethylketocyclazocine | 8.04e-06 | 58 | 187 | 6 | CID000135018 | |
| Drug | fluorescamine | 9.42e-06 | 35 | 187 | 5 | CID000037927 | |
| Drug | benzoquinone | HSP90B1 ABCB1 CXCR4 ATP2C2 HSPA9 PRPF40A ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.43e-06 | 209 | 187 | 10 | CID000004650 |
| Drug | dehydrophenylalanine | 9.65e-06 | 17 | 187 | 4 | CID005702627 | |
| Drug | 2-aminoethyl diphenylborinate | 1.04e-05 | 127 | 187 | 8 | CID000001598 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.24e-05 | 171 | 187 | 9 | 7535_DN | |
| Drug | gramicidin s | 1.25e-05 | 37 | 187 | 5 | CID000073357 | |
| Drug | nitrous oxide | 1.45e-05 | 96 | 187 | 7 | CID000000948 | |
| Drug | Succimer | HSP90B1 ARPP19 MATR3 ZMYND8 IRAK2 ITGA4 ABCB1 PRDM1 BRCA2 SERPINB12 KIF5B DMPK MMP12 MGAT5B FAM162A PHLDA1 CAPN3 AOX1 SKIL SUV39H2 PRPF40A ARFGEF3 ROCK1 PALS2 ATP2B1 SNTA1 | 1.48e-05 | 1264 | 187 | 26 | ctd:D004113 |
| Drug | DB01888 | 1.55e-05 | 19 | 187 | 4 | CID005287990 | |
| Drug | fura 2 | 1.56e-05 | 65 | 187 | 6 | CID000057054 | |
| Drug | TMB-8 | 1.57e-05 | 176 | 187 | 9 | CID000005494 | |
| Drug | indo-1 | 1.77e-05 | 99 | 187 | 7 | CID000105060 | |
| Drug | carbidine | 1.85e-05 | 40 | 187 | 5 | CID000065684 | |
| Drug | NSC406942 | HSP90B1 SRP54 RYR2 RYR3 CXCR4 ATP2C2 FGG HSPA9 DYNC1H1 CAPN3 OPRD1 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 1.86e-05 | 565 | 187 | 16 | CID000001115 |
| Drug | C12E8 | 2.36e-05 | 42 | 187 | 5 | CID000123921 | |
| Drug | 2brh | 2.36e-05 | 21 | 187 | 4 | CID000848641 | |
| Drug | Pyrethroids | 2.61e-05 | 71 | 187 | 6 | CID000005053 | |
| Drug | linopirdine | 2.65e-05 | 43 | 187 | 5 | CID000003932 | |
| Drug | Magnetite Nanoparticles | HSP90B1 ARPP19 MATR3 ZMYND8 IRAK2 ITGA4 ABCB1 PRDM1 BRCA2 SERPINB12 KIF5B DMPK MMP12 MGAT5B FAM162A PHLDA1 CAPN3 AOX1 SKIL SUV39H2 PRPF40A ARFGEF3 ROCK1 PALS2 ATP2B1 SNTA1 | 2.73e-05 | 1310 | 187 | 26 | ctd:D058185 |
| Drug | monobromobimane | 2.82e-05 | 72 | 187 | 6 | CID000114810 | |
| Drug | iodoarylazidoprazosin | 2.96e-05 | 8 | 187 | 3 | CID000115344 | |
| Drug | cocaethylene | 3.05e-05 | 73 | 187 | 6 | CID000002825 | |
| Drug | magnesium | HSP90B1 KIF1A SRP54 RYR2 RYR3 ABCB1 ABCB4 KARS1 SARS1 ATP2C2 OXSR1 FGG MMP12 DYNC1H1 WARS1 OPRD1 ATP6V0A4 HASPIN MTR ROCK1 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 ATP5F1C | 3.31e-05 | 1325 | 187 | 26 | CID000000888 |
| Drug | KB-R7943 | 4.11e-05 | 47 | 187 | 5 | CID004534086 | |
| Drug | C070379 | 4.13e-05 | 199 | 187 | 9 | CID003034747 | |
| Drug | R 8231 | 4.42e-05 | 9 | 187 | 3 | CID003084926 | |
| Drug | CaCl2 | 4.59e-05 | 156 | 187 | 8 | CID000024854 | |
| Drug | Fura-2AM | 4.79e-05 | 79 | 187 | 6 | CID000105091 | |
| Drug | AC1L1G0K | 5.04e-05 | 49 | 187 | 5 | CID000003473 | |
| Drug | C13932 | 5.40e-05 | 206 | 187 | 9 | CID000168297 | |
| Drug | nsc25485 | ABCB1 SLC38A1 ATP2C2 FGG MMP12 SLC12A6 MTR ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.75e-05 | 312 | 187 | 11 | CID000004605 |
| Drug | arabinosyladenine | EARS2 RYR2 RYR3 ABCB1 KARS1 SARS1 CXCR4 ATP2C2 CAPN3 CIT OPRD1 GRK1 HARS2 ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 6.04e-05 | 762 | 187 | 18 | CID000000191 |
| Drug | tricyclohexyltin chloride | 6.27e-05 | 10 | 187 | 3 | CID000076539 | |
| Drug | diC4PC | 6.27e-05 | 10 | 187 | 3 | CID000193375 | |
| Drug | AC1L9061 | 6.71e-05 | 2 | 187 | 2 | CID000390506 | |
| Drug | copper(II) perchlorate | 6.71e-05 | 2 | 187 | 2 | CID000028211 | |
| Drug | caloxin 1b1 | 6.71e-05 | 2 | 187 | 2 | ctd:C510327 | |
| Drug | Maclurin | 6.71e-05 | 2 | 187 | 2 | CID000068213 | |
| Drug | 1,9-dideoxyforskolin | 6.71e-05 | 2 | 187 | 2 | ctd:C047983 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 6.82e-05 | 165 | 187 | 8 | 5227_UP | |
| Drug | K-Cl | EARS2 SRP54 RYR2 RYR3 ATP2C2 DMPK SLC12A6 PLAAT4 RECQL MTR ROCK1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 7.36e-05 | 567 | 187 | 15 | CID000004873 |
| Drug | 1,4-dibromobutane | 7.39e-05 | 53 | 187 | 5 | CID000008056 | |
| Drug | NSC381866 | 8.07e-05 | 169 | 187 | 8 | CID000002287 | |
| Drug | persulfate | 8.57e-05 | 11 | 187 | 3 | CID000024413 | |
| Drug | AC1MBZ1C | MATR3 ATP2C2 STK39 DMPK ARFGEF2 ARFGEF1 HASPIN ATP2B1 YME1L1 ATP2B2 ATP2B3 ATP2B4 | 9.07e-05 | 387 | 187 | 12 | CID000003541 |
| Drug | AC1L1IIA | 9.13e-05 | 172 | 187 | 8 | CID000004591 | |
| Drug | AC1L1JAO | 1.05e-04 | 57 | 187 | 5 | CID000004955 | |
| Drug | AC1MMLID | 1.12e-04 | 92 | 187 | 6 | CID000013245 | |
| Drug | NSC-614848 | 1.14e-04 | 12 | 187 | 3 | CID000357073 | |
| Drug | toxaphene | 1.14e-04 | 58 | 187 | 5 | CID005284469 | |
| Drug | sanguinarine | 1.34e-04 | 60 | 187 | 5 | CID000005154 | |
| Drug | S 16020-2 | 1.47e-04 | 13 | 187 | 3 | CID000177329 | |
| Drug | NSC 59264 | 1.47e-04 | 13 | 187 | 3 | CID000072282 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.51e-04 | 185 | 187 | 8 | 6986_UP | |
| Drug | EGTA-AM | 1.57e-04 | 62 | 187 | 5 | CID000121907 | |
| Drug | FCCP | 1.88e-04 | 101 | 187 | 6 | CID000003330 | |
| Drug | menadione | HSP90B1 ATP2C2 FGG MMP12 AOX1 MTR ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.97e-04 | 300 | 187 | 10 | CID000004055 |
| Drug | desacetylmetipranolol | 2.00e-04 | 3 | 187 | 2 | CID000162812 | |
| Drug | Technetium Tc 99m Sestamibi | 2.00e-04 | 3 | 187 | 2 | ctd:D017256 | |
| Drug | cis-diammineplatinum(II | 2.00e-04 | 3 | 187 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.00e-04 | 3 | 187 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 2.00e-04 | 3 | 187 | 2 | CID000127713 | |
| Drug | sophoradin | 2.00e-04 | 3 | 187 | 2 | CID005321393 | |
| Drug | aminodantrolene | 2.00e-04 | 3 | 187 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 2.00e-04 | 3 | 187 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.00e-04 | 3 | 187 | 2 | CID005748312 | |
| Drug | AC1L87CG | 2.00e-04 | 3 | 187 | 2 | CID000373763 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.02e-04 | 193 | 187 | 8 | 2076_DN | |
| Drug | AC1NS1NG | 2.18e-04 | 147 | 187 | 7 | CID005327099 | |
| Drug | AC1L1IZ2 | HSP90B1 KIF1A RYR2 RYR3 OXSR1 DYNC1H1 ROCK1 RIOK2 YME1L1 ATP5F1C | 2.19e-04 | 304 | 187 | 10 | CID000004795 |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A | 2.24e-04 | 196 | 187 | 8 | 1948_DN | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.64e-11 | 6 | 179 | 5 | DOID:0050429 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 1.80e-05 | 9 | 179 | 3 | EFO_0004606 | |
| Disease | colorectal adenocarcinoma (implicated_via_orthology) | 3.66e-05 | 2 | 179 | 2 | DOID:0050861 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_implicated_in) | 6.44e-05 | 112 | 179 | 6 | DOID:1793 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 9.91e-05 | 301 | 179 | 9 | DOID:684 (is_marker_for) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.09e-04 | 3 | 179 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.09e-04 | 3 | 179 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Hypotension, Orthostatic | 1.09e-04 | 3 | 179 | 2 | C0020651 | |
| Disease | cholestasis (is_implicated_in) | 1.09e-04 | 3 | 179 | 2 | DOID:13580 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.24e-04 | 181 | 179 | 7 | DOID:684 (is_implicated_in) | |
| Disease | Cannabis use, age at onset | 1.98e-04 | 19 | 179 | 3 | EFO_0004847, EFO_0007585 | |
| Disease | factor VII activating protease measurement | 3.51e-04 | 55 | 179 | 4 | EFO_0009368 | |
| Disease | Perrault syndrome (is_implicated_in) | 3.62e-04 | 5 | 179 | 2 | DOID:0050857 (is_implicated_in) | |
| Disease | nasal type extranodal NK/T-cell lymphoma (is_marker_for) | 3.62e-04 | 5 | 179 | 2 | DOID:0080797 (is_marker_for) | |
| Disease | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 | 3.62e-04 | 5 | 179 | 2 | C1832931 | |
| Disease | Perrault syndrome | 5.40e-04 | 6 | 179 | 2 | cv:C0685838 | |
| Disease | synovial sarcoma | 5.40e-04 | 6 | 179 | 2 | C0039101 | |
| Disease | Gonadal dysgenesis XX type deafness | 7.53e-04 | 7 | 179 | 2 | C0685838 | |
| Disease | neutropenia (implicated_via_orthology) | 7.53e-04 | 7 | 179 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 9.57e-04 | 32 | 179 | 3 | EFO_0021870 | |
| Disease | alcohol dependence, risky sexual behaviour measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0007877, MONDO_0007079 | |
| Disease | clopidogrel metabolite measurement | 1.05e-03 | 33 | 179 | 3 | EFO_0007966 | |
| Disease | Liver carcinoma | 1.12e-03 | 507 | 179 | 10 | C2239176 | |
| Disease | symmetrical dimethylarginine measurement | 1.28e-03 | 9 | 179 | 2 | EFO_0006523 | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 1.28e-03 | 9 | 179 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | pyoderma gangrenosum | 1.28e-03 | 9 | 179 | 2 | EFO_0006835 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.28e-03 | 9 | 179 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.28e-03 | 9 | 179 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.28e-03 | 9 | 179 | 2 | C0085548 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 1.28e-03 | 9 | 179 | 2 | EFO_0800314 | |
| Disease | myocardial infarction | 1.40e-03 | 350 | 179 | 8 | EFO_0000612 | |
| Disease | Cannabis Abuse | 1.59e-03 | 10 | 179 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.59e-03 | 10 | 179 | 2 | C0236735 | |
| Disease | primary biliary cholangitis (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.59e-03 | 10 | 179 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Hashish Abuse | 1.59e-03 | 10 | 179 | 2 | C0018614 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.66e-03 | 206 | 179 | 6 | C0152013 | |
| Disease | Papillary thyroid carcinoma | 1.89e-03 | 86 | 179 | 4 | C0238463 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.98e-03 | 41 | 179 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | photoreceptor cell layer thickness measurement | 2.14e-03 | 148 | 179 | 5 | EFO_0803370 | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 2.27e-03 | 43 | 179 | 3 | EFO_0004735, GO_0031427 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 2.27e-03 | 43 | 179 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | survival time, lung adenocarcinoma | 2.32e-03 | 12 | 179 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | motor neuron disease (implicated_via_orthology) | 2.32e-03 | 12 | 179 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | bipolar disorder | MATN1 FSTL5 ZMYND8 KIF5B IFT81 ST6GALNAC3 PALS2 CMTR2 ATP2B2 ATP2B4 | 2.87e-03 | 577 | 179 | 10 | MONDO_0004985 |
| Disease | Malformations of Cortical Development | 3.17e-03 | 14 | 179 | 2 | C1955869 | |
| Disease | pulse pressure measurement, social deprivation | 3.17e-03 | 14 | 179 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.17e-03 | 14 | 179 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Cortical Dysplasia | 3.17e-03 | 14 | 179 | 2 | C0431380 | |
| Disease | epilepsy (implicated_via_orthology) | 3.24e-03 | 163 | 179 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Parkinson disease | 3.57e-03 | 321 | 179 | 7 | MONDO_0005180 | |
| Disease | vital capacity | HTRA1 KIF1A ERC1 C3orf49 RYR2 CXCR4 RTL9 PAN2 PARP9 FAM162A DSP IFT81 ARFGEF2 CTNNA3 ENSA SLC25A31 | 3.64e-03 | 1236 | 179 | 16 | EFO_0004312 |
| Disease | Intrahepatic cholestasis of pregnancy | 4.15e-03 | 16 | 179 | 2 | EFO_0009048 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.15e-03 | 16 | 179 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Cannabis Dependence | 4.69e-03 | 17 | 179 | 2 | C0006870 | |
| Disease | pneumonia, COVID-19 | 5.05e-03 | 113 | 179 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | multiple myeloma (is_implicated_in) | 5.56e-03 | 59 | 179 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | prostate cancer (is_implicated_in) | 5.70e-03 | 117 | 179 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | R-warfarin measurement | 5.73e-03 | 265 | 179 | 6 | EFO_0803324 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 5.85e-03 | 19 | 179 | 2 | EFO_0003100, GO_1902519 | |
| Disease | cancer (implicated_via_orthology) | 6.04e-03 | 268 | 179 | 6 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMGKALIKTHNYSMA | 761 | Q7Z4L5 | |
| FMDTLSDLKMKEYKR | 76 | Q16537 | |
| DSGDYNMAKAKMKNK | 66 | O43768 | |
| SGNLAMLILYAKMKK | 501 | Q5W0A0 | |
| AVSISLMDNKYLKKM | 676 | Q5W0A0 | |
| GMDKLYEMILKRRKS | 171 | P56559 | |
| LVMGYQKKLRSMTDK | 61 | P61073 | |
| KFKKLMTVMGLRESA | 161 | Q8WWZ4 | |
| MYEGKKTKNMFLTRA | 1 | Q9Y6D6 | |
| KMTKEQYIKMNRGIN | 846 | Q9Y6D6 | |
| KKKALTLQKGMVMAY | 201 | Q9BYG8 | |
| TLQKGMVMAYKRKQL | 206 | Q9BYG8 | |
| KMTKEQYIKMNRGIN | 791 | Q9Y6D5 | |
| YNKLTTMQALAEKKM | 196 | Q86XR8 | |
| SKMTLNFGTEMKRKA | 331 | Q8IYT2 | |
| KIKSVSMKIRRMYNP | 371 | Q86XS5 | |
| QSQMKDIEKMYKSGY | 1131 | Q8N2N9 | |
| EKATGDIYAMKVMKK | 116 | O14578 | |
| SSYRRLMVKKKLQEM | 2466 | Q8IZT6 | |
| DSGDYNMAKAKMKNK | 61 | P56211 | |
| ISLAYSVKKMMKDNN | 441 | P20020 | |
| SLAYSVKKMMKDNNL | 466 | Q01814 | |
| AVTISLAYSVKKMMK | 436 | Q16720 | |
| LAYSVKKMMKDNNLV | 441 | Q16720 | |
| ISLAYSVKKMMKDNN | 431 | P23634 | |
| MKMDLSDIKNSYIRK | 466 | O75185 | |
| MAMSSYSLRKVAVEK | 981 | Q06278 | |
| KLVSRALGYITMAKM | 656 | Q9ULI1 | |
| MEVYRSHSKFMKNKV | 426 | Q8IUD2 | |
| ISKDKVDTLIMMYKT | 256 | Q8HWS3 | |
| NKLPVTKMKYSGNLM | 46 | P39900 | |
| TKMKYSGNLMKEKIQ | 51 | P39900 | |
| QLYRKKPGMTMSCAK | 661 | P29074 | |
| YKAFSSEMAKRSKML | 476 | Q8IXQ6 | |
| MLKKYGKSFRKMISL | 256 | O95747 | |
| RLYISKMKSEVKTMV | 591 | P33176 | |
| DKVAKMYSDLRKESM | 741 | P49736 | |
| DDNVMALYKKIMRGK | 211 | Q14680 | |
| MKEKGIYFKLVTMQT | 616 | P08183 | |
| MGASFKNYVMKVAKK | 306 | Q9NPB9 | |
| QSQMKDIEKMYKSGY | 1556 | Q5JPF3 | |
| DDMDGLYTKSKTKMR | 451 | Q5SY16 | |
| FSIRMKMTKNKGLDV | 811 | Q504Q3 | |
| KDIKAAVRNMSYMEK | 336 | P21941 | |
| GKIKNYILMRMKSQA | 521 | P43243 | |
| GYSLEQRTMKMKQRD | 201 | A8MVJ9 | |
| FKRYDNLMKEMTKKP | 561 | Q8IV33 | |
| VNKRSKYTMMKTHLL | 361 | O43187 | |
| VMINKYGRRSKFGMK | 451 | Q16288 | |
| MKRLYGDSAAKIQAM | 201 | Q9NWZ8 | |
| KERYMKMHLAGKTEQ | 121 | Q13442 | |
| NYIRLKRAKMDKSMF | 691 | O95835 | |
| AKLSSMKIKVGQMQY | 236 | Q86W92 | |
| IGKLKMLVYLDMSKN | 226 | Q96NW7 | |
| SYIQGKNEKEMKIKM | 71 | Q9Y5Z4 | |
| GKMKYKRNKIFMEFR | 301 | Q8NHQ9 | |
| GRYLAKKKMRMSEQQ | 761 | Q5VYK3 | |
| LQQMKRHMGLSFKKY | 371 | Q3V5L5 | |
| SKCAKYMLRANMIKE | 446 | Q6N069 | |
| QYHNDMKEIRKKMGR | 476 | Q6P3R8 | |
| GGMQSKMRSYQAKVR | 406 | Q6AI08 | |
| LMLLYSSKKKIFMGL | 511 | Q71SY5 | |
| AKRKSMKPSMYEELD | 66 | Q9Y4A0 | |
| SSTEMNKKMTGRKLI | 261 | Q7L590 | |
| SLSGKKKKRMMYLTT | 336 | Q14168 | |
| KKKRMMYLTTKNAEF | 341 | Q14168 | |
| LEMYSKLRDQMKTKR | 141 | Q9Y2D4 | |
| MKMANSLRGEVLKLY | 1 | Q6IPR1 | |
| VKMKYIIKFSMPGDQ | 556 | Q9UKK3 | |
| KLFEMAYKKMASERE | 646 | P38646 | |
| AVVKMKQTGQVYAMK | 86 | Q09013 | |
| NKMKFGKNMYINRDR | 236 | Q8TAG9 | |
| QGKVTDTASMKYIMR | 441 | Q6P4A8 | |
| KTTEYSKMKNMLLDL | 141 | Q8N475 | |
| ELMKKEGVYFKLVNM | 616 | P21439 | |
| MFGIVRYTKMKTATN | 71 | P41143 | |
| KMTSTTRYKKAEQMF | 476 | O75400 | |
| MKRATQIPSYKKLIM | 271 | P15309 | |
| MKEKQDKIYFMAGSS | 531 | P14625 | |
| KKKMMYLTTRNAEFD | 306 | Q9NZW5 | |
| KSQAVKNTMEMYKRT | 471 | Q9UI47 | |
| KSRKMLEEIMKYEAS | 111 | P02679 | |
| ERLYIIRKSMKMSKS | 281 | Q9H1X3 | |
| RYKSFSIKMLKDMKE | 306 | P87889 | |
| SIKMLKDMKEGVKQY | 311 | P87889 | |
| RYKSFSIKMLKDMKE | 306 | Q9YNA8 | |
| SIKMLKDMKEGVKQY | 311 | Q9YNA8 | |
| RYKSFSIKMLKDMKE | 306 | P62683 | |
| SIKMLKDMKEGVKQY | 311 | P62683 | |
| RYKSFSIKMLKDMKE | 306 | P63145 | |
| SIKMLKDMKEGVKQY | 311 | P63145 | |
| RYKSFSIKMLKDMKE | 306 | P63130 | |
| SIKMLKDMKEGVKQY | 311 | P63130 | |
| RYKSFSIKMLKDMKE | 306 | P62685 | |
| SIKMLKDMKEGVKQY | 311 | P62685 | |
| RYKSFSIKMLKDMKE | 306 | P62684 | |
| SIKMLKDMKEGVKQY | 311 | P62684 | |
| MMQSGEAKRQYKGTL | 251 | Q9H0C2 | |
| ESSKILARKMTQMYK | 1616 | Q9C0G6 | |
| LRKLYKMAGVEDKNM | 2486 | Q9C0G6 | |
| RMEASYLADKKKMKQ | 181 | Q96CN9 | |
| MSEMVKKLYSLVSEK | 486 | Q8WYA0 | |
| RKAMAEKYIMTSAKL | 371 | Q13099 | |
| AITKKKYIGIRMMSL | 376 | Q92743 | |
| ISKRTMRKYKLKNMT | 271 | Q96BT1 | |
| MAAMKDRQKKDTSQY | 231 | Q8NA47 | |
| ITNLLMYVKSMKGLA | 366 | Q8WTW3 | |
| NLVMISRGKESYKMS | 781 | P51587 | |
| GSPYMRSMKQISKEK | 746 | Q6P158 | |
| EHMKKQKYGRIIMTS | 136 | P51659 | |
| MAADKTISKLMTEYK | 2016 | Q5TH69 | |
| KKKLKEGMLSIMSYR | 1046 | P01031 | |
| AKLKTMRQEDYMKTI | 566 | P15924 | |
| LYSQADSKKKSNLMM | 336 | Q96SY0 | |
| TQPMKRDIKKAFYEM | 76 | Q9P0W0 | |
| KNKNGRIVIVMSKYM | 256 | O00257 | |
| QKSLDRKKYMKAAEM | 916 | O43303 | |
| AKYVEDKEKMLSRTM | 191 | Q9HAW0 | |
| HYLTDKMLKQMTFKT | 746 | Q8TF76 | |
| KTYLAVGSMKTLMLN | 646 | P13612 | |
| AKREDQKYALSVMMK | 121 | Q8WXU2 | |
| KGYMKINMLVIELKS | 1391 | Q14204 | |
| DAIREKMKKNYMSNP | 3361 | Q14204 | |
| KSMKMVAAAKYARAE | 46 | P36542 | |
| MTSVLDPNKMYLKAK | 5151 | Q8NDH2 | |
| VQAALAKYKERKMPM | 101 | Q14689 | |
| GYQGAMVEKKILMKV | 231 | Q15835 | |
| IRDAPSDMYKIMKKA | 241 | P20807 | |
| SDMYKIMKKAIERGS | 246 | P20807 | |
| IAKYTSKMMDAIKGT | 926 | Q9ULU4 | |
| KDKYMASRGQKAKSM | 1051 | Q9UHW9 | |
| KMKRKGDRYSMQTSL | 3451 | Q92736 | |
| FQYVLKMETQMKGLK | 111 | Q96PB7 | |
| AGKSYTMMGKQEKDQ | 101 | Q12756 | |
| LLVTMNKKDKTMSYG | 81 | Q5TZ20 | |
| MPTGSMKAVAKQYKR | 476 | Q8NET4 | |
| LRIRYGQTKKMMDKV | 406 | P49591 | |
| KMLVSLKMSYKAAAG | 41 | P23381 | |
| KMIVDRQYMGVSKRK | 181 | Q969X6 | |
| QMEPKMQSKTKIYRR | 486 | Q9UQF0 | |
| FARYLAMNKVKKMKR | 136 | P49590 | |
| EAKHMSLKMAYVSKR | 211 | Q13424 | |
| LTQYTKFAQMVKKMG | 421 | P61011 | |
| MKEKFSMRSGKRNQS | 351 | P12757 | |
| KSNMKTMSAIYQKVR | 726 | Q9ULQ0 | |
| KMVSGMVKHITGSYK | 356 | Q15046 | |
| MYQTGMKILNGSNKK | 186 | Q9UBV2 | |
| MARLYISKMKSEVKS | 586 | O60282 | |
| MQVGMATKIKNYYKR | 711 | Q8IZX4 | |
| AKEMVGQKMKYSIVS | 96 | Q9UL19 | |
| MVQHMKKLLGDKLYT | 531 | Q9UPR0 | |
| RKIKKYGAAMVVMAF | 486 | Q99707 | |
| TQMKRFLKYGNREKM | 426 | O14802 | |
| MKRKYEAMTKLGFKA | 51 | Q99909 | |
| MRKDGNGIVYNMLKK | 161 | Q8NDV1 | |
| IKSGVMTMPEYLKKR | 121 | Q9NY91 | |
| YKMKRARAEKGMEVT | 181 | O95096 | |
| AMNLIKNKRNMTGYK | 546 | O75626 | |
| AYKGHMNKILKMIVS | 616 | P08F94 | |
| QKGNRKKMTYQKMAR | 216 | P17947 | |
| KRKGNRKTMTYQKMA | 156 | Q8N5J4 | |
| MLDAAKNKMRVKISY | 91 | Q96A26 | |
| KNKMRVKISYLMIAL | 96 | Q96A26 | |
| NENKSVKMMTQKGLY | 216 | Q96P63 | |
| LEGTKYSNVMKLLRM | 476 | Q5JPH6 | |
| MKKATKHYEMLANRT | 326 | Q15437 | |
| MKRNYKAMTKLGFKV | 51 | Q16384 | |
| MASTISAYKEKMKEL | 1 | Q9NZ72 | |
| NFAMKSETKLREKMY | 421 | O75969 | |
| KHYLMCERKAGMTKV | 211 | Q9P126 | |
| MDQNIAKYKVKIRGM | 466 | Q6P3X8 | |
| MAVSESQLKKMVSKY | 1 | Q99816 | |
| KSKMFMSRLEKAYEA | 196 | P46063 | |
| VEMSMLNAYKPKSKA | 451 | Q01973 | |
| MKAMQSLKSRGYVKE | 46 | P46783 | |
| LRMKEGKDSKMDVYC | 591 | O94827 | |
| MSRDAVKFGRMSKKQ | 96 | P51449 | |
| MKRKYEAMTKLGFKA | 51 | Q16385 | |
| RKELGKKMLYRDFNM | 341 | Q9ULR3 | |
| NMKTVDCVERKGKYM | 236 | Q8WV24 | |
| ASAKERKLMMKNEYI | 1616 | Q15413 | |
| DGLKMNAAIKMLKEY | 861 | P35590 | |
| MKLNYEVMTKLGFKV | 51 | O60224 | |
| MKRKYEAMTKLGFKA | 51 | O60225 | |
| MKRKYEAMTKLGFNV | 51 | Q7RTT6 | |
| MKRKYEAMTKLGFKA | 51 | Q7RTT5 | |
| MKRKYEAMTKLGFKA | 51 | Q7RTT3 | |
| MSEYKMEKLASDNKR | 851 | Q5VZP5 | |
| KTLVKIKRMSFVMEY | 266 | Q9H5I1 | |
| SNRMRSYKQEMGKLE | 71 | Q96AJ9 | |
| MSRDAVKFGRMSKKQ | 86 | Q92753 | |
| GMSRLEKVYLKNSVM | 81 | Q9HAV4 | |
| SVKETMRKRMSKKYS | 456 | O94885 | |
| NRKDRTGMNYMKVRT | 1166 | Q8WVM7 | |
| YKMMCRQGNLIKDRK | 386 | Q70Z35 | |
| QYPLDMGRKKKMSNA | 71 | Q13573 | |
| MGKVNVAKLRYMSRD | 1 | Q9BVS4 | |
| VYAMKLLSKFEMIKR | 101 | Q13464 | |
| ATKIAKRMVTKFGMS | 681 | Q96TA2 | |
| LNSYKMKMSVILGIV | 536 | Q9HBG4 | |
| LSVSYKKGRMMKDIS | 651 | Q9H1V8 | |
| GAAIIQKAFRKYMMK | 1736 | Q9UI33 | |
| QKAFRKYMMKVTKGD | 1741 | Q9UI33 | |
| YVTLRKTKKMMDLRT | 866 | Q9HAU0 | |
| EMMKKYGKSFRKLLS | 301 | Q9UEW8 | |
| PMMSKLRNYRKDLAK | 76 | Q9UEU0 | |
| YSELKDRSQKKMQMV | 296 | Q9H2H9 | |
| KQAMMEKVRSYGSVL | 376 | Q8NHX9 | |
| MAGTALKRLMAEYKQ | 1 | P60604 | |
| MGMLNSKFKKTRYQA | 746 | Q9HCX4 | |
| AKAGAVKDYIKMMLQ | 321 | Q5FWF4 | |
| GIKIKETMYFAPSMK | 266 | Q96HR8 | |
| GSKMFKLRQMRVEKF | 56 | Q9NP98 |